Sentiment Drives MannKind to Fresh Highs Ahead of Vital Catalyst

3:52:03 PM EDT, Thursday, May 23, 2013 · Brian L. Wilson / Bio-Wire

An enormous amount of hype in the last couple of weeks has sent the diabetes and cancer drug developer MannKind Corporation (NASDAQ: MNKD) soaring, particularly after the company’s first quarter ...

Tickers Mentioned:

Vivus: Management’s Response and Updates

3:12:59 PM EDT, Thursday, May 23, 2013 · Brian L. Wilson / Bio-Wire

I contacted Vivus (NASDAQ: VVUS) directly in an attempt to reach company management to ask them about 10% shareholder First Manhattan and 2% shareholder Alex Denner’s stance against their efforts to ...

Tickers Mentioned:

Amarin Stays Rangebound, Prescriptions Stagnate

2:05:49 PM EDT, Thursday, May 23, 2013 · Brian L. Wilson / Bio-Wire

Amarin Corporation (NASDAQ: AMRN) has been struggling a lot lately as retail channel prescription data for its EPA capsule Vascepa imply that the drug is starting to slow down its ...

Tickers Mentioned:

Vivus Heats Up, Shorts Discouraged on Possible Bidding War

11:49:17 AM EDT, Thursday, May 23, 2013 · Brian L. Wilson / Bio-Wire

Vivus (NASDAQ: VVUS) has been seeing relatively modest growth in QSYMIA (phentermine and topiramate ER) prescriptions since the drug launched in September 2012 under the FDA’s REMS agreement, which restricted ...

Tickers Mentioned:

The Early Movers – who’s hot, who’s not

10:32:38 AM EDT, Thursday, May 23, 2013 · Henry McCusker / Scimitar Equity

Which RegMed companies are making moves in the 1st hour Signs of life … Wright-Medical (WMGI +$0.17) and  Reneuron (LON:RENE +$0.16) are the leaders as today’s market opens… …followed by ...